US2004242504A1PendingUtilityA1

Novel composition and method for the treatment of hypertension

Priority: May 30, 2003Filed: May 30, 2003Published: Dec 2, 2004
Est. expiryMay 30, 2023(expired)· nominal 20-yr term from priority
A61K 36/752A61K 45/06A23L 33/105A61K 33/34A61K 31/375A61K 33/04A61K 36/82A23V 2002/00A23L 33/16A61K 31/221A61K 31/401A61K 31/198A23L 33/175A61K 33/32A61K 33/06A61P 9/02A61K 31/7048A61K 31/352
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides for a composition and method of treatment and prevention of hypertension and its resulting complications comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic proportions.

Claims

exact text as granted — not AI-modified
The following is claimed:  
     
         1 . A method for treatment and/or prevention of hypertension comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycosides, and Epican Forte, in therapeutic proportions.  
     
     
         2 . The method of  claim 1  wherein Quercetin Glycoside is extracted from a plant source selected from the group of onions and apples.  
     
     
         3 . The method of  claim 1  wherein the dose of Quercetin is equivalent to between approximately 100 mg and 15 grams on a daily basis.  
     
     
         4 . The method of  claim 1  wherein the dose of Quercetin is equivalent to between approximately 1 grams and 10 grams on a daily basis.  
     
     
         5 . The method of  claim 1  wherein the dose of Quercetin is repeated daily.  
     
     
         6 . The method of  claim 1 , wherein the Quercetin is administered to a human as part of foods, drinks, health bars, bread or cereals.  
     
     
         7 . The method of  claim 1  wherein Epican Forte is administered in daily amounts indicated in Table 1.  
     
     
         8 . A composition for use in treatment of hypertension in a patient susceptible or suffering from hypertension or its side effects, comprising of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic amounts.  
     
     
         9 . The composition of  claim 8  wherein Quercetin Glycoside is extracted from a plant source selected from the group of onions and apples.  
     
     
         10 . The composition of  claim 8  wherein the dose of Quercetin or Quercetin Glycoside is equivalent to between approximately 100 mg and 15 grams on a daily basis.  
     
     
         11 . The composition of  claim 8  wherein the dose of Quercetin or Quercetin Glycoside is equivalent to between approximately 1 grams and 10 grams on a daily basis.  
     
     
         12 . The composition of  claim 8  wherein the dose of Quercetin or Quercetin Glycoside is repeated daily.  
     
     
         13 . The composition of  claim 8 , wherein the Quercetin or Quercetin Glycoside is administered to a human as part of foods, drinks, health bars, bread or cereals.  
     
     
         14 . The composition of  claim 8  wherein Epican Forte is administered in daily amounts indicated in Table 1.

Join the waitlist — get patent alerts

Track US2004242504A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.